Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9714235
APP PUB NO 20160168129A1
SERIAL NO

14905619

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are protein kinase inhibitors, more particularly novel quinazoline derivatives and pharmaceutical compositions thereof, and method of use thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FOCHON PHARMACEUTICALS LTD401121 NO 100 XINGGUANG AVENUE RENHE STREET NORTHERN NEW AREA YUBEI DISTRICT CHONGQING CHONGQING CITY CHONGQING CITY 401121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Ling Chongqing, CN 357 17312
Jiang, Lihua Chongqing, CN 23 26
Li, Tongshuang Surrey, CA 14 11
Li, Zhifu Chongqing, CN 88 108
Liu, Yanxin Chongqing, CN 22 33
Rong, Yue Chongqing, CN 12 9
Sun, Jing Chongqing, CN 2431 12990
Tian, Qiang Chongqing, CN 46 34
Wang, Weibo Moraga, US 80 402
Wang, Xianlong Chongqing, CN 17 10
Zeng, Fanxin Chongqing, CN 9 15
Zhao, Xingdong Moraga, US 33 26
Zhou, Zuwen Chongqing, CN 17 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 25, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00